Gotowa bibliografia na temat „Beta 2-glycoprotein I”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Beta 2-glycoprotein I”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Beta 2-glycoprotein I"
Inanc, M. "beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?" Rheumatology 36, nr 12 (1.12.1997): 1247–57. http://dx.doi.org/10.1093/rheumatology/36.12.1247.
Pełny tekst źródłaSchousboe, I. "beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway". Blood 66, nr 5 (1.11.1985): 1086–91. http://dx.doi.org/10.1182/blood.v66.5.1086.1086.
Pełny tekst źródłaSchousboe, I. "beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway". Blood 66, nr 5 (1.11.1985): 1086–91. http://dx.doi.org/10.1182/blood.v66.5.1086.bloodjournal6651086.
Pełny tekst źródłaArad, Ariela, Richard A. Furie, Barbara C. Furie i Bruce Furie. "Affinity-Purified Anti-Beta-2 Glycoprotein-1 Antibodies from a Patient with Lupus Anticoagulant-Associated Thrombosis Amplify Thrombus Formation in the Living Mouse." Blood 114, nr 22 (20.11.2009): 146. http://dx.doi.org/10.1182/blood.v114.22.146.146.
Pełny tekst źródłaKertesz, Z., B. B. Yu, A. Steinkasserer, H. Haupt, A. Benham i R. B. Sim. "Characterization of binding of human β2-glycoprotein I to cardiolipin". Biochemical Journal 310, nr 1 (15.08.1995): 315–21. http://dx.doi.org/10.1042/bj3100315.
Pełny tekst źródłaWittevrongel, C., M. Vanrusselt, M. Hoylaerts, J. Vermylen i J. Arnout. "Beta-2-glycoprotein I Dependent Lupus Anticoagulants Form Stable Bivalent Antibody Beta-2-Glycoprotein I Complexes on Phospholipid Surfaces". Thrombosis and Haemostasis 79, nr 01 (1998): 79–86. http://dx.doi.org/10.1055/s-0037-1614224.
Pełny tekst źródłaMarai, Ibrahim, Angela Tincani, Genesio Balestrieri i Yehuda Shoenfeld. "Anticardiolipin and anti-beta-2-glycoprotein I antibodies". Autoimmunity 38, nr 1 (luty 2005): 33–38. http://dx.doi.org/10.1080/08916930400022608.
Pełny tekst źródłaBožič, B., S. Čučnik, T. Kveder i B. Rozman. "Avidity of anti-beta-2-glycoprotein I antibodies". Autoimmunity Reviews 4, nr 5 (czerwiec 2005): 303–8. http://dx.doi.org/10.1016/j.autrev.2005.01.001.
Pełny tekst źródłaMeroni, P. L., D. Mari, D. Monti, R. Coppola, M. Capri, S. Salvioli, A. Tincani, R. Gerli i C. Franceschi. "Anti-beta 2 glycoprotein I antibodies in centenarians". Experimental Gerontology 39, nr 10 (październik 2004): 1459–65. http://dx.doi.org/10.1016/j.exger.2004.08.003.
Pełny tekst źródłaMatsuda, J., N. Saitoh, M. Gotoh, K. Gohchi i M. Tsukamoto. "Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies." Annals of the Rheumatic Diseases 54, nr 1 (1.01.1995): 73–75. http://dx.doi.org/10.1136/ard.54.1.73.
Pełny tekst źródłaRozprawy doktorskie na temat "Beta 2-glycoprotein I"
Giannakopoulos, Bill Clinical School St George Hospital Faculty of Medicine UNSW. "Investigations on beta 2-glycoprotein I and antiphospholipid antibodies". Publisher:University of New South Wales. Clinical School - St George Hospital, 2008. http://handle.unsw.edu.au/1959.4/41440.
Pełny tekst źródłaRahgozar, Soheila Clinical School St George Hospital Faculty of Medicine UNSW. "Studies on beta 2 glycoprotein I and antiphospholipid antibodies". Publisher:University of New South Wales. Clinical School - St George Hospital, 2008. http://handle.unsw.edu.au/1959.4/41475.
Pełny tekst źródłaOlsson, Ola. "Affinity capillary electrophoresis of Beta-2-glycoprotein I and Anionic phospholipids". Thesis, Karlstad University, Faculty of Technology and Science, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-6113.
Pełny tekst źródłaMcNally, Tracy Jane. "An investigation of the role of antiphospholipid antibodies and #beta#2 glycoprotein-I in the modulation of haemostasis". Thesis, University College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.339151.
Pełny tekst źródłaBaldavira, Camila Machado. "Estudo do efeito da beta 2-glicoproteína I no desenvolvimento da rede vascular de membrana corioalantóica de embriões de galinha". Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/5/5160/tde-28072017-134103/.
Pełny tekst źródłaAngiogenesis is the formation of new capillaries from pre-existing vessels, mediated by biochemical signaling events that determine proliferation, migration, differentiation and cell death, and control of tissue growth and remodeling. beta2-glycoprotein I (beta2GPI) is a plasma protein active on vascular function and atherogenesis. ?2GPI monomers present anti-inflammatory and anticoagulant effects. Enzymatic cleavage favors beta2GPI dimerization and induces the appearance of opposing effects. Previous results have shown that beta2GPI monomers and dimers induce different effects upon the proliferation and differentiation of endothelial cells in two-dimensional cultures used as an angiogenesis model. beta2GPI monomers and dimers were obtained by fractioned purification and characterized by SDS-PAGE and ELISA, as described. In this work, three-dimensional Human Umbilical Vein Endothelial Cells (HUVEC) cultures on Matrigel were used to investigate the effects of beta2GPI monomers and dimers upon proliferation, migration and in vitro formation of cellular interaction structures. The beta2GPI monomer performed as a density-dependent endothelial differentiation factor, inducing the formation of elongated phenotypes, membrane extensions and cell-cell interaction structures in three-dimensional HUVEC cultures; the dimeric fraction negatively modulated the proliferation and differentiation of HUVECs. The chorioallantoic membrane (CAM) of chicken embryos was employed to study the effects of beta2GPI upon angiogenesis. In ovo, the beta2GPI dimer prevented angiogenesis and induced embryonic death after 48h exposure, while the monomer allowed embryo development up to the 10th day, despite it induced early changes in the development of chorioallantoic membrane vessels. Microvasculature structures were evaluated through a quantitative morphology approach, based on local binary pattern classification. Previously reported molecular beta2GPI targets were then considered as the source of the observed effects in vitro and in ovo. The obtained results support previous data on the inhibition of the annexin-2/Akt signaling pathway by beta2GPI. Additionally, the Notch signaling pathway is suggested as a target of the antiangiogenic effect of beta2GPI
Wagner, Alison F. Lysle Donald T. "Interactions between intracerebral human immunodeficiency virus-1 glycoprotein 120 and systemic heroin on expression of messenger ribonucleic acid mRNA of inducible nitric oxide synthase, interleukin-1[beta], tumor necrosis factor-[alpha], and cyclooxygenase-2 in hippocampus and cortex brain tissue of the Lewis rat". Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2008. http://dc.lib.unc.edu/u?/etd,1893.
Pełny tekst źródłaTitle from electronic title page (viewed Dec. 11, 2008). "... in partial fulfillment of the requirements for the degree of Master of Arts in the Department of Psychology Behavioral Neuroscience." Discipline: Psychology; Department/School: Psychology. On t.p. and in abstract, [alpha] and [beta] are the Greek letters.
Bordron, Anne. "Effets pathogènes des auto-anticorps anti-cellules endothéliales à l'encontre de leurs cellules cibles". Brest, 2000. http://www.theses.fr/2000BRES3105.
Pełny tekst źródłaWU, TING-YUAN, i 吳庭遠. "Analysis of the interactions of Tafazzin and Beta-2 Glycoprotein I with lipid membrane by hydrogen/deuterium exchange mass spectrometry". Thesis, 2018. http://ndltd.ncl.edu.tw/handle/uqu7b2.
Pełny tekst źródła東海大學
化學系
106
Hydrogen/deuterium exchange (HDX) coupled with mass spectrometry (ESI-MS) has been widely used to study the mechanisms of protein dynamics, domain structure, protein-ligand interactions and protein conformational changes. Beta 2 Glycoprotein I (β2GPI) is a membrane protein and it was discovered to be the major antigen for the antiphospholipid antibodies(aPL Abs) in the antiphospholipid syndrome. The β2GPI complex binds with antibody will interact with some receptors, such as annexin A2, TLR family, glycoprotein Ibα, LRP8 to induce inflammation and prothrombotic. Many studies have suggested that β2GPI is not recognized by aPL Abs in the blood circulation. When negatively charged protein surface become exposed, the domain V of β2GPI will bind to the surface and change conformation. Then the aPL Abs are able to recognize the epitope in domain I of β2GPI. Here, we prepared 1,2-dioleoyl-sn-glycero-3-phospho-L-serine(18:1DOPS) and cardiolipin (CL) vesicles to simulate anion surface membrane. The interactions of the β2GPI with the anion membrane vesicles were analyzed by hydrogen/deuterium exchange mass spectrometry (HDXMS). The exchange level of sequence 21-27 significantly increased after β2GPI interacted with DOPS for 10 min. This results indicated that the interaction between domain I and domain V decreased, which caused the sequence 21-27 protruding out of the circular shape of the protein structure. β2GPI still maintained the circular conformation while interacting with DOPS. The exchange levels of the highly accessible sequences 1-20, 53-77, 175-188, 259-268 and 294-306 slightly decreased due to the nonspecific adsorption between β2GPI and DOPS by electrostatic force and hydrogen bonds. After β2GPI interacted with CL 10 mins. The exchange amount of sequence 21-27 significantly increased. This result was same with DOPS, suggesting the perturbation of sequence 21-27 is a preliminary behavior caused by the phospholipid binding. After β2GPI interacted with CL for 30 min, the exchange levels in several sequences significantly increased, including 1-20, 21-27, 41-51, 70-86, 153-162, 191-198, 196-205, 273-279, 297-306 and 310-316.The increasing of 1-20, 21-27, 41-51, 297-306 and 310-316 indicated that domain I did not interact with domain V and these sequences have been exposed. The increasing deuteration levels in 70-86, 153-162, 191-198, 196-205 and 273-279 indicated β2GPI conformation changed from ring conformation to chain conformation, leading to the exposure of the inner region. Overall, β2GPI could not change the ring conformation while initial contact with lipid membrane, but sequence 21-27 will be exposed. β2GPI continued to drastically change its conformation from ring to chain conformation while staying on the lipid membrane surface.
Hoffmann, Christof Herbert Wolfgang [Verfasser]. "Die Rolle der thrombozytären Kollagenrezeptoren Glycoprotein VI und α2β1-Integrin [Alpha-2-Beta-1-Integrin] für die Thrombozytenadhäsion und Thrombusformation an atheromatöser Plaque / Christof Herbert Wolfgang Hoffmann". 2008. http://d-nb.info/99322122X/34.
Pełny tekst źródłaKsiążki na temat "Beta 2-glycoprotein I"
Alchi, Bassam, i David Jayne. The patient with antiphospholipid syndrome with or without lupus. Redaktor Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0164.
Pełny tekst źródłaCzęści książek na temat "Beta 2-glycoprotein I"
Raby, Anne, Karen Moffat i Mark Crowther. "Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays". W Haemostasis, 387–405. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-339-8_32.
Pełny tekst źródłaMohammed Ali Jassim, Marwa, Majid Mohammed Mahmood i Murtada Hafedh Hussein. "Human Herpetic Viruses and Immune Profiles". W Innate Immunity in Health and Disease. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96340.
Pełny tekst źródłaStreszczenia konferencji na temat "Beta 2-glycoprotein I"
Mansour, MA, M. Badr, H. El Bebawi i A. El Ghobarey. "AB0069 Anti beta 2 glycoprotein antibodies and thrombosis in sle patients". W Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.1223.
Pełny tekst źródłaBorodin, AG, EL Nassonov, AA Baranov i NG Klukvina. "FRI0085 Anti-beta-2- glycoprotein i antibodies in systemic lupus erythematosus patients". W Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.1227.
Pełny tekst źródłaHoffman, R., B. J. Roth, G. W. Sledge, J. Straneva i J. Brandt. "ANALYSIS OF PHORBOL ESTER STIMULATED HUMAN MEGAKARYOCYTE DEVELOPMENT". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642951.
Pełny tekst źródłaFolts, J. D. "A MODEL OF ACUTE PLATELET THROMBUS FORMATION IN STENOSED CORONARY AND CAROTID ARTERIES". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643712.
Pełny tekst źródła